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Abstract
Background: The aging related decline of heat shock factor-1 (HSF1) signaling may be causally related to protein
aggregation diseases. To model such disease, we tried to cripple HSF1 signaling in the Xenopus tadpole.
Results: Over-expression of heat shock factor binding protein-1 did not inhibit the heat shock response in Xenopus. RNAi
against HSF1 mRNA inhibited the heat shock response by 70% in Xenopus A6 cells, but failed in transgenic tadpoles.
Expression of XHSF380, a dominant-negative HSF1 mutant, was embryonic lethal, which could be circumvented by delaying
expression via a tetracycline inducible promoter. HSF1 signaling is thus essential for embryonic Xenopus development.
Surprisingly, transgenic expression of the XHSF380 or of full length HSF1, whether driven by a ubiquitous or a neural specific
promoter, was not detectable in the larval brain.
Conclusions: Our finding that the majority of neurons, which have little endogenous HSF1, refused to accept transgene-
driven expression of HSF1 or its mutant suggests that HSF1 levels are strictly controlled in neuronal tissue.
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Introduction
In healthy cells, accumulation of abnormally folded proteins in
the cytoplasm results in the activation of a stress response system,
the heat shock response (HSR). The HSR is essential for
maintaining proteostasis. Mouse knockout models have shown that
heat shock transcription factor-1 (HSF1) is the key regulator of the
HSR [1–3]. Under normal physiological conditions, HSF1 is
thought to exist as part of an inactive hetero-complex that also
includes Hsp90, p23 and immunophilin. Exposure of cells to
various stressors results in trimerization and hyperphosphorylation
of HSF1, followed by binding of the active trimer to heat shock
elements in the promoters of heat shock protein genes and
subsequent transcription activation (reviewed by [4]). The expres-
sion level and thermostability of HSF1, as well as its affinity for heat
shock elements are significantly decreased in aged cells compared
with young cells, resulting in low efficiency of the HSR ([5]). As the
HSR is already poorly developed in healthy neurons, these cells are
particularly vulnerable to damage resulting from decreased activity
of HSF1 (reviewed by [6]). Restoring the activity of HSF1 or
bypassing the crippled HSF1 may protect the aging cell against
toxic protein aggregates ([7,8]; see also [9,10]). High throughput
screens have already resulted in novel compounds that directly or
indirectly affect the HSR in cell culture systems (reviewed by [11]).
A number of in vivo model systems have been described in which
the role of a failing HSR in the etiology of neurological diseases
can be studied. Mice carrying null mutant HSF1 genes or
expressing a dominant-negative HSF1 are attractive model
systems, because the mouse brain closely resembles the human
brain; however, small offspring and high costs make rodents less
attractive for large scale studies. Invertebrates, such as C. elegans
and Drosophila, are particularly suitable for high throughput
experiments, because they have a large offspring and can be
easily manipulated. Unfortunately, their nervous system differs
considerably from the human brain. Simple vertebrates, such as
Xenopus and Danio, are attractive in vivo model systems to study
many aspects of human neurological diseases. In addition to the
large offspring and low maintenance costs, the basic anatomy of
the fish and amphibian brain is highly similar to that of the
mammalian brain. Furthermore, tadpoles and zebrafish are
translucent, allowing live image analysis of fluorescently labeled
proteins. Microinjection of antisense oligonucleotides has already
been used to transiently inhibit the expression of HSF1 in
zebrafish. This resulted in increased heat shock-induced apoptosis
[12], reduced basal expression levels of Hsp70 and abnormal eye
development [13].
To be able to study the long term effects of decreased HSF1
activity in neurons and perform high throughput experiments, it
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HSF1 is stably inhibited. In this study, we examined if we could
mimic the aging-associated decline of the HSR in a stable manner
by crippling endogenous HSF1 in Xenopus tadpoles. Since a
technique for targeted mutagenesis of endogenous genes in Xenopus
laevis is not (yet) available, we tried to manipulate Xenopus HSF1 via
three alternative strategies: over expression of heat shock factor
binding protein-1 (HSBP1), reported to be a natural inhibitor of
HSF1 [14], over expression of a dominant-negative mutant of
HSF1, and stable transgene-driven RNA interference (RNAi)
directed against HSF1 mRNA. Our surprising finding is that
Xenopus tadpole brain is largely refractory to exogenous
expression of HSF1.
Results
Xenopus heat shock factor binding protein-1 is not an
efficient inhibitor of the heat shock response
HSBP1 is a ,9-kDa polypeptide that was shown to act as a
negative regulator of the HSR in cultured mammalian cells
and in C. elegans in vivo [14]. Since HSBP1 is highly conserved
throughout the animal kingdom [15], we examined whether
transgene-driven over expression of XHSBP1 could be used to
stably inhibit the HSR in Xenopus tadpoles. ClustalW alignment
of the open reading frames of multiple Xenopus laevis HSBP1
ESTs revealed slight variationi nt h eC - t e r m i n a lp a r to ft h e
protein. However, the central coiled coil region thought to be
important for the inhibitory interaction between HSBP1 and
HSF1 [15] is identical in all ESTs and nearly identical to that
of the human protein (Fig. 1A). The code for XHSBP1 was
PCR amplified from adult Xenopus brain cDNA and, to allow
for quick identification of transgenic tadpoles, fused to the 39
end of the code for GFP. Tadpoles with ubiquitous expression
of the GFP-HSBP1 protein developed normally (Fig. 1B,C). To
t e s tw h e t h e ro v e re x p r e s s i o no fG F P - X H S B P 1i n h i b i t e dt h e
HSR in tadpoles, the endogenous Hsp90 level was monitored
by western blot analysis. Basic Hsp90 levels are low in tadpoles
as well as in Xenopus A6 kidney epithelial cells. Upon heat
shock (1 h, 33uC) the level significantly increases, reaching a
maximum after approximately 8 h (Fig. 2A,B). The heat shock-
induced Hsp90 level was not significantly different between
tadpoles expressing GFP-XHSBP1 and non-transgenic controls
(Fig 2B), indicating that GFP-XHSBP1 does not inhibit the
activity of HSF1. Subsequently, we monitored the effect of
GFP-XHSBP1 on an Hsp70 promoter-luciferase reporter
plasmid in transiently transfected A6 cells. Upon heat shock,
the activity of the Hsp70 promoter increased tenfold in the
presence of GFP alone. Co-expression of GFP-XHSBP1
resulted in only 27% reduction of the activity of the Hsp70
promoter (Fig. 2C), which is much less than the 80% reduction
observed by others [14].
HSBP1 is a nuclear protein and the size of the GFP tag might
prevent proper transport of the fusion protein into the nucleus. In
addition, the GFP tag could cause steric hindrance and thereby
interfere with the interaction between XHSBP1 and HSF1.
Therefore we sought ways to simultaneously express GFP and
native XHSBP1 in tadpoles. Since co-expression from an internal
ribosome entry site or from tandemly linked transgenes is
unreliable and inefficient in transgenic tadpoles (our unpublished
observations), we tested whether a ribosome skip system based on
viral 2A peptides ([16]) could be used to simultaneously express
two proteins in Xenopus. Insertion of the code for either the T2A or
F2A peptide between the GFP and DsRed2 open reading frames
resulted in ,100% co-fluorescence in A6 cells in both cases
(Fig. 3A); however, western blot analysis indicated that ribosomal
skipping from the T2A-based bicistronic expression cassette was
almost ,100% efficient, whereas the F2A peptide resulted in only
,50% skipping efficiency (Fig. 3B). A control experiment, in
which GFP and myc-tagged versions of Hsp27 or dominant-
negative HSF1 are expressed from a bicistronic transcription unit
further demonstrated that the second part of the T2A-based
plasmids is also properly expressed (Fig. 3C). The T2A-based
system was then used to test the effect of native HSBP1 on co-
transfected Hsp70-luciferase reporter in A6 cells. The activity of
the Hsp70 promoter was inhibited, but by only ,30% in the
presence of native XHSBP1 (Fig. 3D). In summary, our results
indicate that over expression of XHSBP1 is not a successful
strategy to inhibit the HSR of Xenopus.
RNAi against HSF1 inhibits HSR in A6 cells but is not
effective in tadpoles
As an alternative strategy, we tried to reduce the expression of
HSF1 by means of stable, transgene-driven RNAi. Earlier efforts
to stably inhibit gene expression via RNAi in Xenopus tadpoles were
only partially successful. Whereas expression of exogenous GFP
could be inhibited by co-expressing long GFP dsRNA from RNA
polymerase II promoters [17] or GFP shRNAs from an RNA
polymerase III promoter [18], neither polymerase II nor
polymerase III promoter-based inverted repeat constructs resulted
in stable inhibition of endogenous target genes [17]. We already
showed that the human H1 RNA promoter drives strong and
ubiquitous GFP expression in transgenic Xenopus tadpoles [17].
Thus, we selected a 19-mer sequence optimal for HSF1
knockdown and placed the corresponding inverted repeat under
the control of the human H1 RNA promoter. To allow for future
identification of transgenic tadpoles, the H1-HSF1-sh1 cassette
was linked in tandem with a muscle-specific GFP reporter.
To get a first impression of the inhibitory potential of the
humH1-HSF1-sh1 plasmid, we tested its effect on the Hsp70-
luciferase reporter in A6 cells. The humH1-HSF1-sh1 plasmid
inhibited the heat shock induced activity of the Hsp70 promoter
by only 27% (Fig. 4A). We reasoned that, in Xenopus tadpoles, the
human H1 promoter may not be recognized by the proper RNA
polymerase (polymerase II rather than III), which would result in
shRNAs with long single-stranded extensions that do not induce
RNAi. This would also explain why GFP expression from this
promoter is so efficient [17], despite the fact that RNAs
transcribed from polymerase III promoters are not usually capped
or polyadenylated. Thus, we isolated an H1 (RNAse P) promoter
from Xenopus tropicalis and expressed the HSF1-sh1 from this
promoter. XtH1 promoter-driven HSF1-sh1 reduced the heat
shock induced activity of a co-transfected Hsp70-luciferase
reporter by almost 50% (Fig. 4A). Similar analyses of HSF1-sh2
and HSF1-sh3, which are directed against other parts of the HSF1
mRNA, resulted in, respectively, 71% and 55% inhibition of the
HSR (Fig. 4B).
Since HSF1-sh2 had the strongest inhibitory activity in our in
vitro system, this inverted repeat was used to generate transgenic
tadpoles. Tadpoles carrying the HSF1-sh2 transgene were
identified by muscle-specific expression of the GFP reporter.
GFP-positive tadpoles developed normally and were equally
resistant to sub lethal heat shock as non-transgenic tadpoles (data
not shown). Western blot analysis indicated that heat shock
mediated induction of endogenous Hsp90 expression was not
inhibited in GFP positive tadpoles (Fig. 4C). Thus, despite its
inhibitory activity on the HSR in A6 cells, HSF1-sh2 was not
effective as an inhibitor of the HSR in tadpoles.
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not detectable in transgenic brain
Dominant-negative mutant versions of HSF1 have been
successfully used by others to inhibit the HSR in mammalian
systems (reviewed by [19]). Therefore, we tried to inhibit the HSR
in tadpoles via transgene-mediated expression of dominant-
negative HSF1. The first 380 codons of the XHSF1 open reading
frame (XHSF380), thus lacking the code for the C-terminal trans
activation domain, were PCR amplified from adult Xenopus brain
cDNA. The XHSF380 cDNA was cloned upstream or down-
stream of the GFP code and the effect of expression of the GFP-
XHSF380 fusion protein on the HSR was first tested via reporter
gene analysis of the Hsp70 promoter in transiently transfected A6
cells. Heat shock mediated induction of Hsp70-Luc was
Figure 1. Ubiquitous transgene-driven expression of XHSBP1 in Xenopus tadpoles. (A) ClustalW alignment of human HSBP1 (top) and
HSBP1 sequences deduced from five different Xenopus laevis ESTs. The central coiled coil region is highly conserved between man and Xenopus.( B)
Fluorescence microscope analysis of tadpoles carrying the indicated transgenes. Tadpoles with ubiquitous, high level expression of GFP-HSBP1 look
normal. (C) Western blot analysis of lysates from whole tadpoles carrying the indicated transgenes. Proteins were separated by SDS-PAGE and
analyzed with an anti-GFP antibody.
doi:10.1371/journal.pone.0010158.g001
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XHSF380-GFP, indicating that over expression of XHSF380 is
a powerful way to inhibit the HSR (Fig. 5A).
We next used CMV-GFP-XHSF380 and CMV-XHSF380-
GFP cassettes to generate transgenic tadpoles. GFP-positive larvae
showed clear nuclear fluorescence (Fig. 5B), which is in
accordance with an earlier report that Xenopus HSF1 is a nuclear
protein even in the absence of heat stress [20]. Surprisingly, CMV
promoter-driven expression of GFP-tagged XHSF380 was mainly
restricted to skeletal muscle fibers and undetectable in brain and
spinal cord (Fig. 5B), despite the fact that the CMV promoter is
also highly active in neuronal tissue (data not shown). GFP-positive
larvae (n=40, Table 1) developed poorly, remained small, had a
curved tail and died before reaching the feeding tadpole stage
(Fig. 5B). Embryonic lethality could be due to the high expression
level from the strong CMV promoter; however, replacing the
CMV promoter with the weaker EF1a promoter, did not prevent
the lethal phenotype. Again, GFP fluorescence was not detectable
in neuronal tissues (data not shown), although expression of GFP-
XHSBP1 from the EF1a promoter resulted in strong fluorescence
in brain and spinal cord (Fig. 5B).
In a final effort to target expression of XHSF380 specifically to
thebrain,theCMVpromoterwasreplaced with theneuron-specific
b-tubulin (Ntub) promoter. Injections with Ntub-GFP-XHSF380 or
Ntub-XHSF380-GFP cassettes resulted in ,300 normal larvae
without detectable GFP fluorescence, whereas ,10% of the larvae
derived from parallel injections with a Ntub-GFP cassette showed
strong GFP fluorescence in brain and spinal cord (Fig. 5B, Table 1).
We concluded that GFP-tagged XHSF380 cannot be stably
expressed in Xenopus brain. The observation that both N-terminally
and C-terminally GFP-tagged XHSF380 were undetectable in
neuronal tissue suggested that this was due to tissue-specific
degradation of the fusion protein or the corresponding mRNA,
rather than inefficient translation of the transgene-derived mRNA.
To examine whether putative neuron-specific instability of
XHSF380 was due to the absence of the C-terminal transcription
activation domain, we also generated tadpoles expressing full
length GFP-XHSF1 from the CMV promoter. Surprisingly, the
expression pattern of GFP-XHSF1 was very similar to that of
GFP-XHSF380. Fluorescence was pronounced in nuclei of muscle
tissue, but undetectable in most parts of the brain, except for the
epiphysis, the olfactory lobes and the retinal ganglion cells
(Fig. 5C). In conclusion, the low neuronal expression level of
transgene-derived XHSF380 is an intrinsic property of the Xenopus
HSF1 protein and not a direct result of deletion of the
transcription activation domain.
Since expressing XHSF380 was the most effective strategy to
inhibit the HSR in Xenopus A6 cells, we tried to circumvent the
Figure 2. The effect of exogenous expression of GFP-XHSBP1 on the HSR. (A) Heat shock induced expression of Hsp90. Xenopus A6 kidney
epithelial cells were continuously cultured at room temperature (C) or exposed to a 1 h heat shock (33uC) and then cultured at room temperature for
the indicated times. Cell lysates were subjected to SDS-PAGE and western blot analysis using anti-Hsp90 and anti-tubulin antibodies. (B) Western blot
analysis of Hsp90 levels in tadpoles carrying the indicated transgenes. Lysates were made from whole tadpoles before heat shock (C) or after a 1 h
heat shock at 33uC followed by 6 h recovery at room temperature (HS). The lysates were subjected to SDS-PAGE and western blot analysis using anti-
GFP, anti-Hsp90 and anti-tubulin antibodies. (C) Reporter gene analysis of the effect of GFP-XHSBP1 on the HSR. A6 cells were transfected with
mixtures of an Hsp70-luciferase reporter, a CMV-b-galactosidase reporter and the indicated plasmids. At 48 h after transfection, cells were exposed to
a 1 h heat shock at 33uC. Control cells were left at room temperature. Cell lysates were made at 6 h after heat shock and used for reporter gene
assays. Hsp70 promoter activities were determined by dividing luciferase values by the corresponding b-galactosidase values to correct for varying
transfection efficiencies. The HSR is indicated as fold induction relative to the activity of the Hsp70 promoter in control cells, which was set at 1 (C).
The results are the average of three independent transfections (standard deviations are indicated by error bars).
doi:10.1371/journal.pone.0010158.g002
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PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e10158Figure 3. The effect of exogenous expression of XHSBP1 on the HSR. (A) Fluorescence microscope analysis of reporter gene expression from
bicistronic plasmids. A6 cells were transfected with the indicated dual reporter gene plasmids based on viral 2A peptides. At 24 h after transfection,
GFP and DsRed expression was determined by fluorescence microscope analysis. (B) Western blot analysis of gene expression from bicistronic
plasmids. A6 cells were transfected with the indicated 2A peptide-based plasmids. At 24 h after transfection, cell lysates were made and subjected to
SDS-PAGE and western blot analysis using anti-GFP antibodies. (C) Western blot analysis of gene expression from bicistronic plasmids. A6 cells were
transfected with the indicated 2A peptide-based plasmids. At 24 h after transfection, cell lysates were made and subjected to SDS-PAGE and western
blot analysis using anti-GFP and anti-myc tag antibodies. (D) Reporter gene analysis of the effect of native XHSBP1 on the HSR. A6 cells were
transfected with mixtures of an Hsp70-luciferase reporter, a CMV-b-galactosidase reporter and the indicated plasmids. Relative luciferase activities
and -fold induction were determined as described in the legend to fig. 2C. The results are the average of three independent transfections (standard
deviations are indicated by error bars).
doi:10.1371/journal.pone.0010158.g003
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embryogenesis. The Tet-on system has been successfully used to
regulate the expression of GFP and thyroid hormone receptor in
Xenopus tadpoles [21]. GFP-XHSF380 and XHSF380-GFP cas-
settes under the control of a Tet-responsive CMV promoter were
mixed with a Tet-activator expression cassette and used to generate
transgenic larvae. Embryos were allowed to develop in the absence
of doxycyclin. Subsequently, all normal GFP-negative tadpoles
(n,500) were exposed to doxycyclin to induce expression of GFP-
tagged XHSF380. After 20 h doxycyclin treatment, ,1% of the
tadpoles showed nuclear GFP fluorescence (Fig. 5D), predomi-
nantly in muscle and again not in the nervous system, in spite of the
fact that the TetO system has been shown to drive strong neuronal
expression [21]. Further tadpole development in the presence of
doxycyclin remained normal, indicating that the lethal effect of
XHSF380 is stage-specific and that it can be circumvented by
delaying the expression until after embryogenesis.
Discussion
To mimic the aging-related decline of the HSR in a Xenopus
tadpole model system, we tried to inhibit the activity of HSF1
using three different transgene-mediated strategies. XHSBP1 did
not inhibit the HSR significantly, neither in A6 cells nor in
transgenic tadpoles. Both untagged and GFP-tagged XHSBP1
were poor inhibitors, indicating that the absence of biological
activity did not result from poor import into the nucleus due to the
GFP tag. Perhaps, the expression level of XHSBP1 was insufficient
to exert its inhibitory effect on HSF1, although the GFP
fluorescence signal and western blot analysis suggested that the
transgene was expressed at a very high level throughout the
tadpole. The inhibitory effect of HSBP1 was described in a single
study, wherein hemagglutinin-tagged human HSBP1 was shown
to inhibit the HSR in COS7 cells and the C. elegans orthologue was
shown to inhibit the HSR in nematodes in vivo [14]. The
discrepancy between the published data and our results could be
caused by species-specific differences in the biological activity of
HSBP1, although its strong sequence conservation, especially in
the hydrophobic core, suggests a conserved function. As our efforts
to inhibit the HSR in human HeLa cells using human HSBP1
were also unsuccessful (unpublished results), the proposed
biological function of HSBP1 may have to be reconsidered.
Stable transgene-driven RNAi directed against XHSF1 mRNA
was not an effective means to inhibit the HSR in tadpoles. Earlier,
it was shown that expression of exogenous GFP can be effectively
inhibited by long GFP dsRNAs expressed from RNA polymerase
II promoters [17] or GFP shRNAs expressed from the U6 RNA
polymerase III promoter [18]. Here, we showed that XHSF1
shRNAs expressed from the Xenopus tropicalis H1 RNA promoter
(RNA polymerase III promoter) inhibited the HSR by more than
70% in A6 cells. This implies that the RNAi-mediated inhibition
of XHSF1 expression in A6 cells is highly efficient. Mice that are
heterozygous for a null mutation in the HSF1 gene, still display a
100% HSR, whereas the HSR is completely abolished in
homozygous null mutant mice [2]. There are several reasons
why the XHSF1 shRNA might not be effective in transgenic
tadpoles, despite its potent inhibitory activity in A6 cells. The
heterogeneous genetic background of the parental frogs combined
with the pseudotetraploid nature of their genome may result in
mismatches between the shRNA sequence and the endogenous
XHSF1 sequences, which would negatively influence the RNAi
effect. Essential components of the RNAi machinery, such as the
Dicer enzyme, may be present at suboptimal levels in tadpoles
compared with A6 cells. In addition, activation of the RNAi
machinery may require a threshold level of shRNAs that is
reached in transiently transfected A6 cells, but not in stably
transgenic tadpoles.
The dominant-negative XHSF380 mutant completely abolished
the HSR in A6 cells. In tadpoles, its expression from a ubiquitously
active promoter resulted in embryonic lethality, indicating that
HSF1 signaling is required for normal Xenopus development.
Surprisingly, HSF1 null mice also show abnormalities that are not
directly related to stress, such as defects in female and male germ
cells, placenta, and central nervous system [1–3,22–24]. Together
with our Xenopus data, these results indicate that HSF1 also
functions under normal physiological conditions. The basal
expression levels of several genes are reduced in specific tissues
Figure 4. The effect of XHSF1 shRNAs on the HSR. (A,B) Reporter
gene analysis of (A) the effect of HSF1 shRNAs expressed from the
human or Xenopus H1 promoter, and (B) the effect of different shRNAs
expressed from the Xenopus H1 promoter, on the HSR. A6 cells were
transfected with mixtures of an Hsp70-luciferase reporter, a CMV-b-
galactosidase reporter and the indicated plasmids. Relative luciferase
activities and -fold induction were determined as described in the
legend to fig. 2C. The results are the average of three independent
transfections (standard deviations are indicated by error bars). (B)
Western blot analysis of Hsp90 levels in tadpoles carrying the indicated
transgenes. Lysates were made from whole tadpoles before heat shock
(C) or after a 1 h heat shock at 33uC followed by 6 h recovery at room
temperature (HS). The lysates were subjected to SDS-PAGE and western
blot analysis using anti-Hsp90 and anti-tubulin antibodies.
doi:10.1371/journal.pone.0010158.g004
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PLoS ONE | www.plosone.org 6 April 2010 | Volume 5 | Issue 4 | e10158Figure 5. Transgene-driven expression of dominant-negative HSF1 in Xenopus larvae. (A) Reporter gene analysis of the effect of GFP-
XHSF380 or XHSF380-GFP on the HSR. A6 cells were transfected with mixtures of an Hsp70-luciferase reporter, a CMV-b-galactosidase reporter and
the indicated plasmids. Relative luciferase activities and -fold induction were determined as described in the legend to fig. 2C. The results are the
average of three independent transfections (standard deviations are indicated by error bars). (B) Fluorescence microscope analysis of GFP-tagged
XHSF380 constitutively expressed from either the CMV or the EF1a promoter in transgenic Xenopus larvae. Larvae with high constitutive expression of
GFP-tagged XHSF380 develop poorly and never reach the feeding tadpole stage. Also shown are transgenic Xenopus larvae showing strong neuronal
expression of GFP when driven by the EF1a or the Ntub promoter. (C) Fluorescence microscope analysis of transgenic Xenopus larvae expressing full
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compared with wild type mice [25,26]. Whether reduced
expression of orthologous genes causes the embryonic lethality
observed in tadpoles expressing XHSF380 remains to be
determined. HSF1 target genes are expressed during early Xenopus
development [27]. Embryonic lethality could be successfully
circumvented by delaying the expression of XHSF380 until the
feeding tadpole stage and a stable Xenopus line carrying a
tetracyclin-inducible XHSF380 transgene may provide a useful
model system to study the in vivo effects of a crippled HSR.
Surprisingly, GFP-tagged XHSF380 was not detectable in
neuronal tissues, even when a neuron-specific promoter was used
to specifically target expression to the brain. Expression from the
ubiquitously active CMV or EF1a promoter resulted in clear GFP
fluorescence in the nuclei of skeletal muscle fibers, indicating that
the GFP-XHSF380 cassettes were properly transcribed and
translated in non-neuronal tissue. Furthermore, parallel injections
with an Ntub-GFP transgene resulted in high neuron-specific GFP
fluorescence, indicating that the Ntub promoter functions properly
(Fig. 5B). Thus, the absence of detectable GFP-tagged XHSF380
in transgenic brain and spinal cord most likely results from
instability of the mRNA or protein. Full length GFP-XHSF1
expressed from the CMV promoter was also undetectable in most
parts of the brain, but clearly visible in e.g. muscle and
pronephros, again indicating that it is an intrinsic property of
HSF1 or its coding sequence that causes the low neuronal
expression. Similarly, a dominant positive HSF1 was not expressed
in the brain of transgenic mice, in spite of the use of an ubiquitous
promoter [7,28]. Our data thus suggest the intriguing possibility
that the low HSR in neuronal tissue [6] is due to tissue-specific
differences in the half-life of HSF1.
Materials and Methods
Ethics statement
Animal experiments were carried out in accordance with the
European Communities Council Directive 86/609/EEC for
animal welfare, and were approved by the Radboud University
Animal Experimentation Committee (permit TRC 99/15072 to
generate and house transgenic Xenopus).
Animal care
Female South-African claw-toed frogs (Xenopus laevis) were
obtained from Xenopus Express (Cape Town, South-Africa) and
kept in water tanks at 18uC at the Central Animal Facility of the
Radboud University Nijmegen. Ovulation was induced by
injection of 500 units hCG (Pregnyl; Organon) into the dorsal
lymph sac.
DNA constructs
Oligonucleotides that were used to generate recombinant DNA
constructs are listed in the on line supplementary information
(Table S1). New vectors were constructed to express proteins with
N- or C-terminally fused GFP in Xenopus A6 cells and tadpoles.
The chimeric enhancer/promoter of the Xenopus elongation factor-
1a (EF1a) gene was PCR amplified from pEF-GFP3 (kindly
donated by Dr. Paul Krieg; [29]) using the EF1a primer set, cut
with SalI and HindIII and used to replace the CMV promoter of
the Xenopus vector pCS2+ [30], resulting in pEF2+. The code for
GFPdelAUG was PCR amplified from pIRES2-EGFP (Clontech)
using the GFPdelAUG primer set, and cloned into the BamHI and
XbaI sites of pEF2+, yielding pEF-GFPdelAUG. Similarly, the
code for GFPdelSTOP was amplified from pIRES2-EGFP using
the GFPdelSTOP primer set, and cloned into the BamHI and XhoI
sites of pEF2+, yielding pEF-GFPdelSTOP. Bicistronic expression
vectors, based on viral 2A peptides, were generated as follows:
pEF-GFP-T2A-delSTOP was made by annealing the T2A primer
set, and cloning the double stranded oligo into the EcoRI and BglII
sites of pEF-GFPdelSTOP. pEF-F2A-delAUG-GFP was made by
annealing the F2A primer set, and cloning the double stranded
oligo into the EcoRI and XhoI sites of pEF-GFPdelAUG.
Adult Xenopus laevis brain mRNA was used as a source for
XHSBP1, XHSF and XHSF380 cDNA. Total RNA was isolated
using the RNeasy kit (Qiagen) and copied into cDNA using the
Marathon kit (Clontech). The 243-bp XHSBP1 cDNA was PCR
amplified from the Xenopus brain cDNA library using the XHSBP1
primer set, and cloned into the EcoRI and XhoI sites of pEF-
GFPdelSTOP, yielding pEF-GFP-XHSBP1. To express native
protein, the XHSBP1 cDNA was also cloned into the EcoRI and
XhoI sites of pEF-GFP-T2A-delSTOP, resulting in pEF-GFP-
length GFP-tagged XHSF1 from the CMV promoter. Fluorescence is pronounced in kidney, epiphysis, nasal epithelium, olfactory lobes, gills, retinal
ganglion cell layer (RGC) and tail muscle nuclei. (D) Fluorescence microscope analysis of doxycycline-induced expression of GFP-tagged XHSF380
expressed in transgenic Xenopus larvae. A mixture of TetO-XHSF380-GFP and CS2+rtTA2A-M2 (CMV-TAM2) cassettes was used to generate transgenic
Xenopus larvae. The larvae were allowed to develop in the absence of doxycycline until the feeding tadpole stage. GFP-negative larvae were exposed
to doxycycline for 20 h and then monitored for GFP fluorescence.
doi:10.1371/journal.pone.0010158.g005
Table 1. Expression of XHSF380-GFP, GFP-XHSF380 or GFP from ubiquitous and neuron-specific promoters in transgenic Xenopus
larvae.
Transgene total number of larvae number of GFP positive larvae phenotype of GFP positive larvae
EF1a-GFP 75 8 normal
CMV-XHSF380-GFP 280 28 lethal
CMV-GFP-XHSF380 290 12 lethal
EF1a-GFP-XHSF380 255 13 lethal
Ntub-GFP 160 16 normal
Ntub-XHSF380-GFP 155 0 N.A.
Ntub-GFP-XHSF380 145 0 N.A.
CMV-GFP-XHSF1 225 6 normal
doi:10.1371/journal.pone.0010158.t001
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amplified from the Xenopus brain cDNA library using the
XHSF380-C primer set, corresponding to GenBank sequence
BC087308 from the NIH Xenopus initiative [31]. XHSF380 was
cloned into the EcoRI and XhoI sites of pEF-GFPdelSTOP,
yielding pEF-GFP-XHSF380. In parallel, the XHSF380 cDNA
was PCR amplified using the XHSF380-N primer set, cut with
BglII and EcoRI, and cloned into the BamHI and EcoRI sites of
pEF-GFPdelAUG, resulting in pEF-XHSF380-GFP. To drive
strong ubiquitous expression of XHSF380-GFP and GFP-
XHSF380, the EF1a promoter was replaced with the CMV
promoter, resulting in pCMV-GFP-XHSF380 and pCMV-
XHSF380-GFP. To drive neuron-specific expression, the EF1a
promoter was replaced with the neural b-tubulin (Ntub) promoter,
resulting in pNtub-GFP-XHSF380 and pNtub-XHSF380-GFP.
Inducible expression constructs were generated by PCR amplify-
ing the TetO promoter from pCS2+[tetO]::GFP using the TetO
primer set, cutting the PCR fragment with SalI and HindIII and
replacing the EF1a promoter with the TetO promoter, resulting in
pTetO-GFP-XHSF380 and pTetO-XHSF380-GFP. The Tet-
activator plasmid pCS2+rtTA2A-M2 and reporter plasmid
pCS2+[tetO]::GFP were kindly donated by Dr. Biswajit Das
[21]. Full length pCMV-GFP-XHSF1 was made by amplifying the
39 part of the XHSF1 code from the Xenopus brain cDNA library
using the XHSF1 primer set, cutting the PCR fragment with
EcoRV and XhoI and replacing the truncated EcoRV-XhoI fragment
of pCMV-GFP-XHSF380 with the full length fragment.
The bicistronic reporter construct pEF-GFP-T2A-DsRed2 was
made by amplifying the code for DsRed2 from pDsRed2-N1
(Clontech) using the DsRed2-C primer set, cutting the PCR
fragment with BamHI and XhoI, and cloning it into the BglII and
XhoI sites of pEF-GFP-T2AdelSTOP. Similarly, pEF-DsRed2-
F2A-GFP was made by PCR amplifying the code for DsRed2del-
STOP from pDsRed2-N1 using the DsRed2-N primer set, and
cloning the PCR fragment into the BamHI and EcoRI sites of pEF-
F2A-delAUG-GFP. The Hsp70-luciferase reporter construct pHL
was described earlier [32].
For the purpose of inducing stable transgene-driven RNAi, new
vectors were constructed that drive the synthesis of short hairpin
RNAs (shRNAs) from an H1 RNA promoter. The human H1
RNA promoter was PCR amplified from genomic DNA using the
H1 primer set, cut with SalI and HindIII and used to replace the
CMV promoter of pCS2+, resulting in pH1. To facilitate
identification of transgenic tadpoles, a Cac-GFP-tkpolyA cassette,
driving expression of the GFP reporter protein from the muscle-
specific cardiac actin (Cac) promoter, was cloned into the NotI site
of pH1, resulting in pH1CG2+. The Xenopus laevis RNAse P RNA
(accession number X56558) and human H1 RNA sequences were
used in a BLAST search of the Xenopus tropicalis genome (http://
genome.jgi-psf.org), resulting in the identification of multiple
copies of the Xenopus H1 RNA gene. Based on the alignment of six
intact copies of the gene, the XtH1 primer set was designed and
used to PCR amplify a Xenopus tropicalis H1 RNA promoter
(XtH1). The human H1 RNA promoter in the pH1CG2+ vector
was replaced with the XtH1 promoter using SalI and HindIII,
resulting in the pXtH1CG2+ vector.
Target sequences for RNAi-mediated decay of XHSF1
mRNA were chosen according to http://www.promega.com/
siRNADesigner (Promega) and https://rnaidesigner.invitrogen.
com/rnaiexpress (Invitrogen). pH1CG2+XHSF-sh1 was made by
annealing of the XHSF-sh1a primer set, and cloning the double
stranded oligo into the BglII and HindIII sites of pH1CG(A)2+.
pXtH1CG2+XHSF1-sh1, -sh2 and –sh3 were made by annealing
the XHSF-sh1, -sh2, and -sh3 primer sets, respectively, and
cloning the double stranded oligos into the BspEI and HindIII sites
of pXtH1CG2+.
The control plasmid pEF-GFP was made as follows: GFP
cDNA was excised from pIRES2-EGFP (BD Sciences-Clontech)
using MscI and NotI (filled-in), introduced into the EcoRV site of
pBluescript SK-, then excised again using HindIII (filled) and
EcoRI and introduced into the StuI and EcoRI sites of pEF2+.
All plasmids were sequence verified.
Xenopus transgenesis
All expression cassettes, consisting of promoter, cDNA and
polyadenylation signal, were excised from their plasmid vector
backbones using SalI and NotI, separated by agarose gel
electrophoresis, and recovered from agarose slices using the
GFX gel band purification kit (Amersham). Transgenesis of
Xenopus laevis was performed according to Kroll and Amaya [33],
with modifications [34]. In summary: 250,000 sperm nuclei were
mixed with ,200 ng DNA fragment, incubated for 15 min at
room temperature and diluted in 500 ml sperm dilution buffer
(250 mM sucrose, 75 mM KCl, 0.5 mM spermidine trihy-
drochloride, 0.2 mM spermidine tetrahydrochloride, 5 mM
MgCl2, pH 7.4). Eggs were dejellied in 2% cystein/16MMR
(16MMR: 0.1 M NaCl, 0.02 M KCl, 0.01 M MgCl2, 0.015 M
CaCl2 en 0.5 M HEPES pH 7.5), transferred to 6% Ficoll/
0.46MMR and injected with 10 nl of the diluted nuclei/DNA
mixture at 17uC. At the 4-cell stage, the embryos were transferred
to 6% Ficoll/0.16MMR and incubated overnight at 17uC. At the
gastrula stage, the embryos were transferred to 0.16MMR and
incubated at 22uC. GFP-positive tadpoles were photographed
using a MZ FLIII fluorescence stereomicroscope provided with a
DC200 camera (Leica microsystems, Switzerland).
Western blot analysis
Tadpoles or A6 cell pellets were snap frozen in liquid nitrogen
and homogenized in 100 ml SDS-PAGE sample mix. Protein
samples (25 ml) were separated in 12% polyacrylamide gels and
transferred to nitrocellulose transfer membrane (Protran, Schlei-
cher and Schuell) using a Biorad Mini-PROTEAN II Electro-
phoresis cell according to the manufacturer’s instructions (Biorad).
For western blot analysis, monoclonal a-GFP antibody (Cat.
no. 632375; Clontech) was used at a 1:5000 dilution. Monoclonal
a-tubulin antibody (kindly donated by Mr. Huib Croes, Dept. of
Cell Biology, NCMLS, Radboud University Nijmegen, The
Netherlands) was used at a 1:1000 dilution. Monoclonal anti-
Hsp90 antibody (610418, BD Biosciences) was used at a 1:1000
dilution. Proteins were visualized using the SuperSignal West Pico
Chemiluminescent Substrate kit (Pierce).
Tissue culture, transfections, and reporter gene assays
Xenopus A6 kidney epithelial cells (ATCC CCL-1020) were
kindly donated by Ms. Stieneke van den Brink from the Hubrecht
laboratory (Utrecht, the Netherlands). The cells were cultured at
room temperature (,25uC) in 70% Leibovitz medium supple-
mented with 10% fetal calf serum (FCS) and 25 mM Hepes
pH 7.2. Transient transfection was performed using Fugene-6
(Roche) according to the manufacturer’s instructions. Cells were
seeded on six-well plates (2.5610
5 per well) and on the next day
transfected with ,1 mg plasmid per well in serum-free medium.
The following day, the transfection mix was replaced with medium
supplemented with FCS. For GFP and DsRed fluorescence
analysis, cells were cultured on cover slips and fixed in 4%
paraformaldehyde at 24 h after transfection. Fluorescence was
monitored with a Leica DM RA microscope (Leica Microsystems),
coupled to a Cohu high performance CCD camera. For luciferase
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galactosidase, 200 ng pHL, and 800 ng of the plasmid indicated in
the figures. At 48 h after transfection, cells were either left at room
temperature (control) or incubated at 33uC for 1 hour (heat shock).
After 6 h recovery at room temperature, cells were lysed in 200 ml
reporter lysis mix (2.5 mM, 0.05% Tween 20, 0.05% Tween 80)
for 10 min. For the b-galactosidase assay, 40 ml cell lysate was
mixed with 100 ml phosphate solution [100 mM Na-phosphate
pH 8.2, 10 mM MgCl2, 1% Galacton-Plus (Tropix)]. After
30 min incubation at room temperature, 150 ml accelerator II
(Tropix) was added and luminescence was measured with the
Lumat LB 9507 tube luminometer (Berthold technologies). For the
luciferase assay, 40 ml cell lysate was mixed with 50 ml luciferin
solution and luminescence was again measured with the Lumat
luminometer. All reporter gene assays were performed in triplo.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0010158.s001 (0.05 MB
DOC)
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